{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:28:47Z","timestamp":1787671727289,"version":"build-2736575974"},"reference-count":122,"publisher":"China Science Publishing & Media Ltd.","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["81970390"],"award-info":[{"award-number":["81970390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["81470569"],"award-info":[{"award-number":["81470569"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innovation Foundation for Postgraduate of Hunan Province","award":["CX2017B550"],"award-info":[{"award-number":["CX2017B550"]}]},{"name":"Innovation Foundation for Postgraduate of Hunan Province","award":["CX2016B490"],"award-info":[{"award-number":["CX2016B490"]}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","award":["2018JJ2341"],"award-info":[{"award-number":["2018JJ2341"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National College Students Innovation and Entrepreneurship Fund","award":["201710555015"],"award-info":[{"award-number":["201710555015"]}]},{"name":"National College Students Innovation and Entrepreneurship Fund","award":["201710555010"],"award-info":[{"award-number":["201710555010"]}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.1093\/abbs\/gmaa176","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T12:11:49Z","timestamp":1609330309000},"page":"273-282","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":37,"title":["Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment"],"prefix":"10.3724","volume":"53","author":[{"given":"Jinwen","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"null","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"Cui J","year":"2019","unstructured":"Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol, 2019, 17: 181-192.","journal-title":"Nat Rev Microbiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","volume":"24","author":"Su S","year":"2016","unstructured":"Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol, 2016, 24: 490-502.","journal-title":"Trends Microbiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.virusres.2015.02.025","volume":"206","author":"Yang D","year":"2015","unstructured":"Yang D, Leibowitz JL. The structure and functions of coronavirus genomic 3\u2032 and 5\u2032 ends. Virus Res, 2015, 206: 120-133.","journal-title":"Virus Res"},{"key":"null","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","volume":"348","author":"Drosten C","year":"2003","unstructured":"Drosten C, G\u00fcnther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med, 2003, 348: 1967-1976.","journal-title":"N Engl J Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"Zaki AM","year":"2012","unstructured":"Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med, 2012, 367: 1814-1820.","journal-title":"N Engl J Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"Zhou P","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, 579: 270-273.","journal-title":"Nature"},{"key":"null","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"Lu R","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020, 395: 565-574.","journal-title":"Lancet"},{"key":"null","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","volume":"27","author":"Wu A","year":"2020","unstructured":"Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe, 2020, 27: 325-328.","journal-title":"Cell Host Microbe"},{"key":"null","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"Chan JF","year":"2020","unstructured":"Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect, 2020, 9: 221-236.","journal-title":"Emerg Microbes Infect"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0170-0","volume":"5","author":"Shang W","year":"2020","unstructured":"Shang W, Yang Y, Rao Y, Rao X. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. NPJ Vaccines, 2020, 5:","journal-title":"NPJ Vaccines"},{"key":"null","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"Li F","year":"2016","unstructured":"Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol, 2016, 3: 237-261.","journal-title":"Annu Rev Virol"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"Rothan HA","year":"2020","unstructured":"Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun, 2020, 109:","journal-title":"J Autoimmun"},{"key":"null","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"Yan R","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science, 2020, 367: 1444-1448.","journal-title":"Science"},{"key":"null","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 2020, 181: 271-280.e8.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"Letko M","year":"2020","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol, 2020, 5: 562-569.","journal-title":"Nat Microbiol"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007236","volume":"14","author":"Song W","year":"2018","unstructured":"Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog, 2018, 14:","journal-title":"PLoS Pathog"},{"key":"null","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"Li F","year":"2005","unstructured":"Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science, 2005, 309: 1864-1868.","journal-title":"Science"},{"key":"null","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"Walls AC","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 2020, 181: 281-292.e6.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"Wrapp D","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 2020, 367: 1260-1263.","journal-title":"Science"},{"key":"null","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"Zou X","year":"2020","unstructured":"Zou X, Chen K, Zou J, Han P, Hao J, Z. H. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med, 2020, 14: 185-192.","journal-title":"Front Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00380-019-01478-y","volume":"35","author":"Zhou X","year":"2020","unstructured":"Zhou X, Zhang P, Liang T, Chen Y, Liu D, Yu H. Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis and coronary heart disease. Heart Vessels, 2020, 35: 153-161.","journal-title":"Heart Vessels"},{"key":"null","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"Hamming I","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol, 2004, 203: 631-637.","journal-title":"J Pathol"},{"key":"null","volume":"9","author":"Deng SQ","year":"2020","unstructured":"Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med, 2020, 9:","journal-title":"J Clin Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3348\/kjr.2020.0112","volume":"21","author":"Wei J","year":"2020","unstructured":"Wei J, Xu H, Xiong J, Shen Q, Fan B, Ye C, Dong W. 2019 novel coronavirus (COVID-19) pneumonia: serial computed tomography findings. Korean J Radiol, 2020, 21: 501-504.","journal-title":"Korean J Radiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","volume":"133","author":"Liu K","year":"2020","unstructured":"Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl), 2020, 133: 1025-1031.","journal-title":"Chin Med J (Engl)"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1091","volume":"368","author":"Chen T","year":"2020","unstructured":"Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ, 2020, 368:","journal-title":"BMJ"},{"key":"null","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"Chen N","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395: 507-513.","journal-title":"Lancet"},{"key":"null","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Ruan Q","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med, 2020, 46: 846-848.","journal-title":"Intensive Care Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020, 395: 1054-1062.","journal-title":"Lancet"},{"key":"null","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","volume":"323","author":"Grasselli G","year":"2020","unstructured":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA, 2020, 323: 1574-1581.","journal-title":"JAMA"},{"key":"null","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Wu Z","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 2020, 323: 1239-1242.","journal-title":"JAMA"},{"key":"null","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"Li B","year":"2020","unstructured":"Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol, 2020, 109: 531-538.","journal-title":"Clin Res Cardiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.amjmed.2017.05.049","volume":"130","author":"Sandoval Y","year":"2017","unstructured":"Sandoval Y, Smith SW, Sexter A, Thordsen SE, Bruen CA, Carlson MD, Dodd KW. Type 1 and 2 myocardial infarction and myocardial injury: clinical transition to high-sensitivity cardiac troponin I. Am J Med, 2017, 130: 1431-1439.e4.","journal-title":"Am J Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"446.e5","DOI":"10.1016\/j.amjmed.2015.11.006","volume":"129","author":"Sarkisian L","year":"2016","unstructured":"Sarkisian L, Saaby L, Poulsen TS, Gerke O, Jangaard N, Hosbond S, Diederichsen AC. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med, 2016, 129: 446.e5-446.e21.","journal-title":"Am J Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395: 497-506.","journal-title":"Lancet"},{"key":"null","first-page":"567","volume":"48","author":"Chen C","year":"2020","unstructured":"Chen C, Chen C, Yan JT, Zhou N, Zhao JP, Wang DW. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi, 2020, 48: 567-571.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"null","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"Wang D","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020, 323: 1061-1069.","journal-title":"JAMA"},{"key":"null","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","volume":"36","author":"Alhogbani T","year":"2016","unstructured":"Alhogbani T. Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Ann Saudi Med, 2016, 36: 78-80.","journal-title":"Ann Saudi Med"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-333","volume":"15","author":"Moni MA","year":"2014","unstructured":"Moni MA, Li\u00f2 P. Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies. BMC Bioinform, 2014, 15:","journal-title":"BMC Bioinform"},{"key":"null","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1378\/chest.126.2.509","volume":"126","author":"Liu CL","year":"2004","unstructured":"Liu CL, Lu YT, Peng MJ, Chen PJ, Lin RL, Wu CL, Kuo HT. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest, 2004, 126: 509-517.","journal-title":"Chest"},{"key":"null","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1093\/infdis\/jiaa113","volume":"221","author":"Cui Y","year":"2020","unstructured":"Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L, Wang L. A 55-day-old female infant infected with 2019 novel coronavirus disease: presenting with pneumonia, liver injury, and heart damage. J Infect Dis, 2020, 221: 1775-1781.","journal-title":"J Infect Dis"},{"key":"null","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00134-020-05987-7","volume":"46","author":"Cao J","year":"2020","unstructured":"Cao J, Hu X, Cheng W, Yu L, Tu WJ, Liu Q. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Med, 2020, 46: 851-853.","journal-title":"Intensive Care Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5858\/2004-128-195-AODDTS","volume":"128","author":"Chong PY","year":"2004","unstructured":"Chong PY, Chui P, Ling AE, Franks TJ, Tai DY, Leo YS, Kaw GJ. Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. Arch Pathol Lab Med, 2004, 128: 195-204.","journal-title":"Arch Pathol Lab Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s15010-015-0720-y","volume":"43","author":"Arabi YM","year":"2015","unstructured":"Arabi YM, Harthi A, Hussein J, Bouchama A, Johani S, Hajeer AH, Saeed BT. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection, 2015, 43: 495-501.","journal-title":"Infection"},{"key":"null","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/cid\/cix1144","volume":"67","author":"Blackburn R","year":"2018","unstructured":"Blackburn R, Zhao H, Pebody R, Hayward A, Warren-Gash C. Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015. Clin Infect Dis, 2018, 67: 8-17.","journal-title":"Clin Infect Dis"},{"key":"null","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","volume":"17","author":"Zheng YY","year":"2020","unstructured":"Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol, 2020, 17: 259-260.","journal-title":"Nat Rev Cardiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa1406761","volume":"373","author":"Templin C","year":"2015","unstructured":"Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med, 2015, 373: 929-938.","journal-title":"N Engl J Med"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.14780","volume":"3","author":"Jabri A","year":"2020","unstructured":"Jabri A, Kalra A, Kumar A, Alameh A, Adroja S, Bashir H, Nowacki AS. Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic. JAMA Netw Open, 2020, 3:","journal-title":"JAMA Netw Open"},{"key":"null","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/jama.2020.4326","volume":"323","author":"Arentz M","year":"2020","unstructured":"Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA, 2020, 323: 1612-1614.","journal-title":"JAMA"},{"key":"null","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","volume":"75","author":"Driggin E","year":"2020","unstructured":"Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol, 2020, 75: 2352-2371.","journal-title":"J Am Coll Cardiol"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114114","volume":"178","author":"Wu L","year":"2020","unstructured":"Wu L, O\u2019Kane AM, Peng H, Bi Y, Motriuk-Smith D, Ren J. SARS-CoV-2 and cardiovascular complications: from molecular mechanisms to pharmaceutical management. Biochem Pharmacol, 2020, 178:","journal-title":"Biochem Pharmacol"},{"key":"null","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","volume":"135","author":"Connors JM","year":"2020","unstructured":"Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood, 2020, 135: 2033-2040.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"Tang N","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 2020, 18: 844-847.","journal-title":"J Thromb Haemost"},{"key":"null","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020, 382: 1708-1720.","journal-title":"N Engl J Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"Klok FA","year":"2020","unstructured":"Klok FA, Kruip M, NJM VDM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res, 2020, 191: 145-147.","journal-title":"Thromb Res"},{"key":"null","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"Panigada M","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost, 2020, 18: 1738-1742.","journal-title":"J Thromb Haemost"},{"key":"null","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/jth.14854","volume":"18","author":"Ranucci M","year":"2020","unstructured":"Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, Falco M. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost, 2020, 18: 1747-1751.","journal-title":"J Thromb Haemost"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007485","author":"Chau VQ","year":"2020","unstructured":"Chau VQ, Giustino G, Mahmood K, Oliveros E, Neibart E, Oloomi M, Moss N. Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19. Circ Heart Fail, 2020,","journal-title":"Circ Heart Fail"},{"key":"null","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ejhf.1828","volume":"22","author":"Tavazzi G","year":"2020","unstructured":"Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, Sepe PA. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail, 2020, 22: 911-915.","journal-title":"Eur J Heart Fail"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02939-x","volume":"24","author":"Yu Y","year":"2020","unstructured":"Yu Y, Xu D, Fu S, Zhang J, Yang X, Xu L, Xu J. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study. Crit Care, 2020, 24:","journal-title":"Crit Care"},{"key":"null","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","volume":"395","author":"Li H","year":"2020","unstructured":"Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, Su X. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet, 2020, 395: 1517-1520.","journal-title":"Lancet"},{"key":"null","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Xu Z","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020, 8: 420-422.","journal-title":"Lancet Respir Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/22221751.2020.1732837","volume":"9","author":"Chen W","year":"2020","unstructured":"Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, Li L. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect, 2020, 9: 469-473.","journal-title":"Emerg Microbes Infect"},{"key":"null","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","volume":"9","author":"Zhang W","year":"2020","unstructured":"Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect, 2020, 9: 386-389.","journal-title":"Emerg Microbes Infect"},{"key":"null","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tmrv.2020.02.003","volume":"34","author":"Chang L","year":"2020","unstructured":"Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev, 2020, 34: 75-80.","journal-title":"Transfus Med Rev"},{"key":"null","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"Donoghue M","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res, 2000, 87: E1-9.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1523-1755.2002.kid559.x","volume":"62","author":"Ferrario CM","year":"2002","unstructured":"Ferrario CM, Averill DB, Brosnihan KB, Chappell MC, Iskandar SS, Dean RH, Diz DI. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat. Kidney Int, 2002, 62: 1349-1357.","journal-title":"Kidney Int"},{"key":"null","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1161\/ATVBAHA.113.301320","volume":"33","author":"Yang JM","year":"2013","unstructured":"Yang JM, Dong M, Meng X, Zhao YX, Yang XY, Liu XL, Hao PP. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler Thromb Vasc Biol, 2013, 33: 1978-1985.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"null","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/01.HYP.0000215289.51180.5c","volume":"47","author":"Santos RA","year":"2006","unstructured":"Santos RA, Castro CH, Gava E, Pinheiro SV, Almeida AP, Paula RD, Cruz JS. Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice. Hypertension, 2006, 47: 996-1002.","journal-title":"Hypertension"},{"key":"null","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.ki.5000321","volume":"70","author":"Chappel MC","year":"2006","unstructured":"Chappel MC, Ferrario CM. ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney Int, 2006, 70: 8-10.","journal-title":"Kidney Int"},{"key":"null","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.toxlet.2010.08.021","volume":"199","author":"Pei Z","year":"2010","unstructured":"Pei Z, Meng R, Li G, Yan G, Xu C, Zhuang Z, Ren J. Angiotensin-(1-7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs\/TIMPs. Toxicol Lett, 2010, 199: 173-181.","journal-title":"Toxicol Lett"},{"key":"null","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","volume":"39","author":"Oudit GY","year":"2009","unstructured":"Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest, 2009, 39: 618-625.","journal-title":"Eur J Clin Invest"},{"key":"null","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1113\/expphysiol.2007.040048","volume":"93","author":"Imai Y","year":"2008","unstructured":"Imai Y, Kuba K, Penninger JM. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol, 2008, 93: 543-548.","journal-title":"Exp Physiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"Kuba K","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med, 2005, 11: 875-879.","journal-title":"Nat Med"},{"key":"null","volume":"94","author":"Wan Y","year":"2020","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol, 2020, 94:","journal-title":"J Virol"},{"key":"null","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"Zhang H","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med, 2020, 46: 586-590.","journal-title":"Intensive Care Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Liu Y","year":"2020","unstructured":"Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci, 2020, 63: 364-374.","journal-title":"Sci China Life Sci"},{"key":"null","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"Channappanavar R","year":"2017","unstructured":"Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol, 2017, 39: 529-539.","journal-title":"Semin Immunopathol"},{"key":"null","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ajem.2007.10.031","volume":"26","author":"Wang H","year":"2008","unstructured":"Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med, 2008, 26: 711-715.","journal-title":"Am J Emerg Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","volume":"13","author":"Liu Q","year":"2016","unstructured":"Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol, 2016, 13: 3-10.","journal-title":"Cell Mol Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet, 2020, 395: 1033-1034.","journal-title":"Lancet"},{"key":"null","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"Qin C","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis, 2020, 71: 762-768.","journal-title":"Clin Infect Dis"},{"key":"null","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijcard.2014.05.035","volume":"176","author":"Cirillo P","year":"2014","unstructured":"Cirillo P, Cimmino G, D\u2019Aiuto E, Di Palma V, Abbate G, Piscione F, Golino P. Local cytokine production in patients with acute coronary syndromes: a look into the eye of the perfect (cytokine) storm. Int J Cardiol, 2014, 176: 227-229.","journal-title":"Int J Cardiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/imt-2016-0020","volume":"8","author":"Tanaka T","year":"2016","unstructured":"Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy, 2016, 8: 959-970.","journal-title":"Immunotherapy"},{"key":"null","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","volume":"91","author":"Mann DL","year":"2002","unstructured":"Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res, 2002, 91: 988-998.","journal-title":"Circ Res"},{"key":"null","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.jacc.2013.12.030","volume":"63","author":"Tsimikas S","year":"2014","unstructured":"Tsimikas S, Duff GW, Berger PB, Rogus J, Huttner K, Clopton P, Brilakis E. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). J Am Coll Cardiol, 2014, 63: 1724-1734.","journal-title":"J Am Coll Cardiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1096\/fj.09-149815","volume":"24","author":"Krishnamurthy P","year":"2010","unstructured":"Krishnamurthy P, Lambers E, Verma S, Thorne T, Qin G, Losordo DW, Kishore R. Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J, 2010, 24: 2484-2494.","journal-title":"FASEB J"},{"key":"null","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1161\/01.CIR.0000094737.21775.32","volume":"108","author":"Li SS","year":"2003","unstructured":"Li SS, Cheng CW, Fu CL, Chan YH, Lee MP, Chan JW, Yiu SF. Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study. Circulation, 2003, 108: 1798-1803.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"Yang X","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med, 2020, 8: 475-481.","journal-title":"Lancet Respir Med"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"Lai CC","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents, 2020, 55:","journal-title":"Int J Antimicrob Agents"},{"key":"null","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.2020.2342","volume":"323","author":"MacLaren G","year":"2020","unstructured":"MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA, 2020, 323: 1245-1246.","journal-title":"JAMA"},{"key":"null","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1089\/ars.2007.1587","volume":"9","author":"Preston IR","year":"2007","unstructured":"Preston IR. Clinical perspective of hypoxia-mediated pulmonary hypertension. Antioxid Redox Signal, 2007, 9: 711-721.","journal-title":"Antioxid Redox Signal"},{"key":"null","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI200524408","volume":"115","author":"Giordano FJ","year":"2005","unstructured":"Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest, 2005, 115: 500-508.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/jama.2020.3972","volume":"323","author":"Adams JG","year":"2020","unstructured":"Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA, 2020, 323: 1439-1440.","journal-title":"JAMA"},{"key":"null","volume":"17","author":"Wang C","year":"2020","unstructured":"Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health, 2020, 17:","journal-title":"Int J Environ Res Public Health"},{"key":"null","first-page":"147","volume":"49","author":"Xu K","year":"2020","unstructured":"Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, Li J. Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2020, 49: 147-157.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"null","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1196\/annals.1410.079","volume":"1148","author":"Ueyama T","year":"2008","unstructured":"Ueyama T, Kasamatsu K, Hano T, Tsuruo Y, Ishikura F. Catecholamines and estrogen are involved in the pathogenesis of emotional stress-induced acute heart attack. Ann N Y Acad Sci, 2008, 1148: 479-485.","journal-title":"Ann N Y Acad Sci"},{"key":"null","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/clc.4950260705","volume":"26","author":"Kelly RF","year":"2003","unstructured":"Kelly RF, Sompalli V, Sattar P, K. K. Increased TIMI frame counts in cocaine users: a case for increased microvascular resistance in the absence of epicardial coronary disease or spasm. Clin Cardiol, 2003, 26: 319-322.","journal-title":"Clin Cardiol"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1136\/fmch-2020-000361","volume":"8","author":"Li DKT","year":"2020","unstructured":"Li DKT, Zhu S. Contributions and challenges of general practitioners in China fighting against the novel coronavirus crisis. Fam Med Community Health, 2020, 8:","journal-title":"Fam Med Community Health"},{"key":"null","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"Wang M","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res, 2020, 30: 269-271.","journal-title":"Cell Res"},{"key":"null","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","volume":"382","author":"Holshue ML","year":"2020","unstructured":"Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C. First case of 2019 novel coronavirus in the United States. N Engl J Med, 2020, 382: 929-936.","journal-title":"N Engl J Med"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117477","volume":"248","author":"Elfiky AA","year":"2020","unstructured":"Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci, 2020, 248:","journal-title":"Life Sci"},{"key":"null","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/cid\/ciaa199","volume":"71","author":"Wu J","year":"2020","unstructured":"Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, Xu W. Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis, 2020, 71: 706-712.","journal-title":"Clin Infect Dis"},{"key":"null","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.002","volume":"81","author":"Deng L","year":"2020","unstructured":"Deng L, Li C, Zeng Q, Liu X, Li X, Zhang H, Hong Z. Arbidol combined with LPV\/r versus LPV\/r alone against corona virus disease 2019: a retrospective cohort study. J Infect, 2020, 81: e1-e5.","journal-title":"J Infect"},{"key":"null","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"Gao J","year":"2020","unstructured":"Gao J, Tian Z, X. Y. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends, 2020, 14: 72-73.","journal-title":"Biosci Trends"},{"key":"null","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","volume":"59","author":"Chu CM","year":"2004","unstructured":"Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, Kao RY. Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax, 2004, 59: 252-256.","journal-title":"Thorax"},{"key":"null","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"Cao B","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med, 2020, 382: 1787-1799.","journal-title":"N Engl J Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","volume":"7","author":"White NJ","year":"2007","unstructured":"White NJ. Cardiotoxicity of antimalarial drugs. Lancet Infect Dis, 2007, 7: 549-558.","journal-title":"Lancet Infect Dis"},{"key":"null","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1054-8807(02)00118-7","volume":"11","author":"Roos JM","year":"2002","unstructured":"Roos JM, Aubry MC, Edwards WD. Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease. Cardiovasc Pathol, 2002, 11: 277-283.","journal-title":"Cardiovasc Pathol"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1188-2","volume":"16","author":"Haeusler IL","year":"2018","unstructured":"Haeusler IL, Chan XHS, Gu\u00e9rin PJ, White NJ. The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review. BMC Med, 2018, 16:","journal-title":"BMC Med"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160306","volume":"11","author":"Limsreng S","year":"2016","unstructured":"Limsreng S, Marcy O, Ly S, Ouk V, Chanroeurn H, Thavary S, Boroath B. Dyslipidemias and elevated cardiovascular risk on lopinavir-based antiretroviral therapy in Cambodia. PLoS One, 2016, 11:","journal-title":"PLoS One"},{"key":"null","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/jac\/dki063","volume":"55","author":"Montes ML","year":"2005","unstructured":"Montes ML, Pulido F, Barros C, Condes E, Rubio R, Cepeda C, Dronda F. Lipid disorders in antiretroviral-naive patients treated with lopinavir\/ritonavir-based HAART: frequency, characterization and risk factors. J Antimicrob Chemother, 2005, 55: 800-804.","journal-title":"J Antimicrob Chemother"},{"key":"null","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1086\/503807","volume":"193","author":"Grubb JR","year":"2006","unstructured":"Grubb JR, Dejam A, Voell J, Blackwelder WC, Sklar PA, Kovacs JA, Cannon RO. Lopinavir-ritonavir: effects on endothelial cell function in healthy subjects. J Infect Dis, 2006, 193: 1516-1519.","journal-title":"J Infect Dis"},{"key":"null","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BJ20040634","volume":"383","author":"Rice GI","year":"2004","unstructured":"Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J, 2004, 383: 45-51.","journal-title":"Biochem J"},{"key":"null","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"Ferrario CM","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation, 2005, 111: 2605-2610.","journal-title":"Circulation"},{"key":"null","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yjmcc.2016.05.012","volume":"97","author":"Wang X","year":"2016","unstructured":"Wang X, Ye Y, Gong H, Wu J, Yuan J, Wang S, Yin P. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice. J Mol Cell Cardiol, 2016, 97: 180-190.","journal-title":"J Mol Cell Cardiol"},{"key":"null","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","volume":"75","author":"Danser AHJ","year":"2020","unstructured":"Danser AHJ, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension, 2020, 75: 1382-1385.","journal-title":"Hypertension"},{"key":"null","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"Meng J","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect, 2020, 9: 757-760.","journal-title":"Emerg Microbes Infect"},{"key":"null","author":"Zhou Y","year":"2020","unstructured":"Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Sun R, Tian Z. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. Nat Sci Rev, 2020,","journal-title":"Nat Sci Rev"},{"key":"null","unstructured":"Chinese Clinical Trial Registry. A Multicenter, Randomized Controlled Trial for the Efficacy and Safety of Tocilizumab in the Treatment of New Coronavirus Pneumonia (COVID-19). 6 March 2020, date last accessed. Feb 13, 2020. http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=49409 ()."},{"key":"null","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.atherosclerosis.2013.04.031","volume":"229","author":"Strang AC","year":"2013","unstructured":"Strang AC, Bisoendial RJ, Kootte RS, Schulte DM, Dallinga-Thie GM, Levels JH, Kok M. Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis. Atherosclerosis, 2013, 229: 174-181.","journal-title":"Atherosclerosis"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omx104","volume":"2018","author":"Ezad S","year":"2018","unstructured":"Ezad S, Cheema H, Collins N. Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction. Oxf Med Case Rep, 2018, 2018:","journal-title":"Oxf Med Case Rep"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/4223E20689C64D579F321DE4C6CE4C98","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmaa176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/abbs\/article-pdf\/53\/3\/273\/37091616\/gmaa176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/4223E20689C64D579F321DE4C6CE4C98","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:26:34Z","timestamp":1670631994000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmaa176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":122,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,1,11]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmaa176","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}